Valeant price target raised to $20 from $17 at BMO Capital. BMO Capital analyst Gary Nachman raised his price target on Valeant to $20, saying the company’s “impressive” Q1 results demonstrate “good returns” on some of its strategic investments. Nachman also raised his FY18 EPS target to $3.42 from $3.12 to reflect the company’s raised FY18 guidance. The analyst keeps his Market Perform rating amid continued uncertainty about sustainability of certain revenue drivers and potential contribution from its “key new product launches”.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.